Jazz Pharmaceuticals plc (JAZZ) stock
JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30119% above fair value
$241.55+1.18 (+0.49%)
Close on Nov 13, 2026Market cap $15.68BP/E 78.7Yield –
Jazz Pharmaceuticals statistics
93 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 23, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/OCF Ratio
- 9.26
- 12.99
Enterprise valuationIndustry
- EV / Sales
- 3.90
- 2.57
- EV / EBIT
- 43.18
- 19.31
- EV / FCF
- 11.34
- 22.27
Share statisticsIndustry
- Shares Change (YoY)
- 6.45%
- 10.8%
- Float
- 63M
- 49M
- Shares Held by Insiders
- 3.44%
- 11.7%
- Shares Held by Institutions
- 99.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 6M
- –
- Short Interest Change
- -1.12%
- -0.80%
- Short % of Float
- 9.25%
- 9.01%
- Short % of Shares Outstanding
- 8.93%
- 6.30%
- Days to Cover
- 7.67
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $266.38
- –
- 52-Week Low
- $136.56
- –
- 20-Day Moving Average
- $223.21
- –
- 50-Day Moving Average
- $229.13
- –
- 200-Day Moving Average
- $220.03
- –
- Average True Range (14)
- $7.70
- –
- Price Change (1 Week)
- 2.89%
- -1.15%
- Price Change (1 Month)
- 12.7%
- -4.87%
- Price Change (3 Months)
- -2.74%
- -21.0%
- Price Change (6 Months)
- 5.59%
- -20.6%
- Price Change (YTD)
- 42.1%
- -23.6%
- Price Change (1 Year)
- 76.7%
- -22.4%
- Price Change (3 Years)
- 93.5%
- -29.5%
- Price Change (5 Years)
- 73.1%
- -77.9%
- Price Change (10 Years)
- 114.0%
- -65.4%
- Average Volume (10 Days)
- 831,877
- –
- Average Volume (20 Days)
- 806,001
- –
- Average Volume (90 Days)
- 848,550
- –
- Relative Volume
- 0.58
- 0.70
- Relative Strength Index (14)
- 60.8
- 43.4
- Volatility (1 Year)
- 38.7%
- 80.1%
- Beta (5 Years)
- 0.53
- 1.07
MarginsIndustry
- Pretax Margin
- 5.51%
- -11.6%
- EBITDA Margin
- 9.03%
- -27.7%
- FCF Margin
- 34.4%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 5.05%
- -49.9%
- Return on Assets (ROA)
- 1.76%
- -40.6%
- Return on Invested Capital (ROIC)
- 4.54%
- -32.9%
- Return on Capital Employed (ROCE)
- 4.50%
- -37.9%
Financial positionIndustry
- Current Ratio
- 1.82
- 3.30
- Quick Ratio
- 1.47
- 2.39
- Debt / Equity
- 1.33
- 0.49
- Debt / EBITDA
- 13.07
- 3.15
- Debt / FCF
- 3.43
- 4.65
- Net Debt / EBITDA
- 6.37
- 1.97
GrowthIndustry
- Revenue Growth (YoY)
- 13.5%
- 6.82%
- FCF Growth (YoY)
- 21.3%
- 6.85%
- Revenue Growth (3Y CAGR)
- 5.26%
- 2.25%
- Revenue Growth (5Y CAGR)
- 12.5%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.40
- 0.40
- Revenue Per Employee
- $1.63M
- $429.29K
- Profits Per Employee
- $71.26K
- -$689.41K
- Employee Count
- 2,890
- 74
- WACC
- 7.21%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $259.84M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$2.71B
- $17.76M
- Net Cash Per Share
- -$41.79
- $0.80
- Equity (Book Value)
- $4.19B
- $53.89M
- Book Value Per Share
- $64.57
- $1.50
- Tangible Book Value
- -$1.78B
- $27.13M
- Working Capital
- $2.08B
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$70.75M
- -$1.00M
- FCF Per Share
- $24.98
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 1.31%
- -21.8%
- FCF Yield
- 10.3%
- -9.44%
Taxes and interestIndustry
- Income Tax
- $53.66M
- $73.00K
- Effective Tax Rate
- 20.6%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $66.79
- $19.34
- Graham Upside
- -72.4%
- -46.6%
- Altman Z-Score
- 1.97
- 0.23
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | JAZZ | S&P 500 | Difference | JAZZ per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +14.8% | -3.0% | +17.8 pts | ||
| 3 months | -1.7% | -2.8% | +1.0 pts | ||
| Year to date | +42.1% | +11.5% | +30.6 pts | ||
| 1 year | +70.5% | +13.5% | +57.0 pts | ||
| 3 years | +98.0% | +77.7% | +20.3 pts | +25.6% | +21.1% |
| 5 years | +73.1% | +72.6% | +0.5 pts | +11.6% | +11.5% |
| 10 years | +113.6% | +308.2% | −194.6 pts | +7.9% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
6M JAZZ shares were sold short on Oct 30, 2026, down 1.1% from the previous report, or 9.25% of the shares available to trade. At recent volumes it would take 7.7 days to buy them back. Over the last 20 sessions, 62.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,798,338 | -1.1% | 755,707 | 7.7 |
| Oct 15, 2026 | 5,863,736 | +7.0% | 854,807 | 6.9 |
| Sep 30, 2026 | 5,479,715 | +17.2% | 845,809 | 6.5 |
| Sep 15, 2026 | 4,676,811 | +1.1% | 647,877 | 7.2 |
| Aug 31, 2026 | 4,624,690 | +27.9% | 1,256,220 | 3.7 |
| Aug 14, 2026 | 3,614,639 | +7.7% | 949,549 | 3.8 |
| Jul 31, 2026 | 3,355,182 | -11.7% | 629,781 | 5.3 |
| Jul 15, 2026 | 3,801,863 | +8.6% | 786,595 | 4.8 |
| Jun 30, 2026 | 3,500,138 | -11.2% | 932,540 | 3.8 |
| Jun 15, 2026 | 3,941,396 | -8.1% | 930,091 | 4.2 |
| May 29, 2026 | 4,290,867 | -11.5% | 842,467 | 5.1 |
| May 15, 2026 | 4,849,332 | -4.7% | 1,033,745 | 4.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?